Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More Pharma Industry News Noxopharm bags new funding to fuel game-changing cancer treatments Noxopharm Limited, an Australian biotech powerhouse, has successfully raised A$2.1 million in funding through the issuance of convertible… byPallavi MadhirajuSeptember 29, 2024